Halozyme Therapeutics Inc. buy Benchmark Co.
Start price
03.02.26
/
50%
€64.40
Target price
03.02.27
-
Performance (%)
12.14%
Price
04.08.26
€72.22
Summary
This prediction is currently active. The prediction currently has a performance of 12.14%. This prediction currently runs until 03.02.27. The prediction end date can be changed by Benchmark_Co_ at any time. Benchmark_Co_ has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Halozyme Therapeutics Inc. | -1.447% | -1.447% |
| iShares Core DAX® | 3.258% | 2.069% |
| iShares Nasdaq 100 | 5.697% | -0.604% |
| iShares Nikkei 225® | 7.770% | -4.746% |
| iShares S&P 500 | 2.795% | 2.251% |
Comments by Benchmark_Co_ for this prediction
In the thread Halozyme Therapeutics Inc. diskutieren
Halozyme Therapeutics (NASDAQ:HALO) had its "buy" rating reaffirmed by analysts at Benchmark Co..
Ratings data for HALO provided by MarketBeat
Stopped prediction by Benchmark_Co_ for Halozyme Therapeutics Inc.
Halozyme Therapeutics Inc.
Start price
Target price
Perf. (%)
€68.12
21.07.26
21.07.26
-
21.07.27
21.07.27
6.02%
04.08.26
04.08.26
Halozyme Therapeutics Inc.
Start price
Target price
Perf. (%)
€59.58
03.06.26
03.06.26
-
03.06.27
03.06.27
21.22%
04.08.26
04.08.26
Halozyme Therapeutics Inc.
Start price
Target price
Perf. (%)
€60.94
19.02.26
19.02.26
€76.30
19.02.27
19.02.27
18.51%
04.08.26
04.08.26
Halozyme Therapeutics Inc.
Start price
Target price
Perf. (%)
€66.40
24.09.25
24.09.25
€76.27
24.09.26
24.09.26
8.77%
04.08.26
04.08.26
Halozyme Therapeutics Inc.
Start price
Target price
Perf. (%)
€54.68
20.02.25
20.02.25
€71.72
20.02.26
20.02.26
8.56%
21.02.26
21.02.26
Halozyme Therapeutics Inc.
Start price
Target price
Perf. (%)
€49.87
08.08.24
08.08.24
€55.00
08.08.25
08.08.25
10.25%
09.08.25
09.08.25
Halozyme Therapeutics Inc.
Start price
Target price
Perf. (%)
€48.68
25.06.24
25.06.24
€56.00
25.06.25
25.06.25
-7.99%
26.06.25
26.06.25
Halozyme Therapeutics Inc.
Start price
Target price
Perf. (%)
€36.23
16.04.24
16.04.24
€46.98
16.04.25
16.04.25
43.42%
17.04.25
17.04.25
Halozyme Therapeutics Inc.
Start price
Target price
Perf. (%)
€31.35
19.01.24
19.01.24
€45.94
19.01.25
19.01.25
69.19%
20.01.25
20.01.25
Halozyme Therapeutics Inc.
Start price
Target price
Perf. (%)
€33.23
20.10.23
20.10.23
€47.17
20.10.24
20.10.24
45.44%
21.10.24
21.10.24